World Anti-Doping Agency and the Fonds de recherche du Québec have joined together to launch a Request for Applications that aims to develop biomarkers of doping


» Share this page


Wednesday July 1, 2020

World Anti-Doping Agency and the Fonds de recherche du Québec have joined together to launch a Request for Applications that aims to develop biomarkers of doping

The development of novel biomarkers of doping is a key priority for anti-doping research. The challenges for the development and implementation of new biomarkers for anti-doping testing not only involve specific analytical approaches and omics technologies, but also require complementary expertise and research approaches that have been advanced in Quebec for the development of clinical biomarkers.



 

Applications eligible for this RFA should aim to develop:

  1. biomarkers of relevant prohibited substances or methods, or
  2. biomarkers of known confounding factors encountered in anti-doping testing.

For details, read the Request for Applications.



Back to news list